Answer
The mean terminal phase half-life of mirvetuximab soravtansine after the first dose is 4.9 days.
Sources for this answer
- ELAHERE 5 mg/mL concentrate for solution for infusionAbbVie Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 2Document updated
Sources checked